Logitech Announces Q2 Fiscal Year 2026 Results
28.10.2025 21:05:00 CET | Business Wire | Press Release
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the second quarter of Fiscal Year 2026.
- Sales were $1.19 billion, up 6 percent in US dollars and 4 percent in constant currency compared to Q2 of the prior year.
- GAAP gross margin was 43.4 percent, down 20 basis points compared to Q2 of the prior year. Non-GAAP gross margin was 43.8 percent, down 30 basis points compared to Q2 of the prior year.
- GAAP operating income was $191 million, up 19 percent compared to Q2 of the prior year. Non-GAAP operating income was $230 million, up 19 percent compared to Q2 of the prior year.
- GAAP earnings per share (EPS) was $1.15, up 21 percent compared to Q2 of the prior year. Non-GAAP EPS was $1.45, up 21 percent compared to Q2 of the prior year.
- Cash flow from operations was $229 million. The quarter-ending cash balance was $1.4 billion.
- The Company returned $340 million to shareholders through its annual dividend payment and share repurchases.
“We delivered another strong quarter, driving growth and excellent profitability through our strategic priorities,” said Hanneke Faber, Logitech chief executive officer. “We continue to demonstrate resilience in a challenging environment. In the quarter, we announced 16 new products, including the much-anticipated MX Master 4 mouse and a wide array of new Gaming products. We executed well across all regions, and saw strong demand growth across both B2B and consumer channels.”
“This quarter, our teams delivered outstanding operating income growth and continued to drive robust gross margins, thanks to disciplined operational execution and cost controls,” said Matteo Anversa, Logitech chief financial officer. “This strong performance shows our guiding principles in action, as we play offense, manage costs and remain agile in an uncertain environment.”
Outlook
Our financial outlook for the third quarter of FY26 reflects a pragmatic balance between the strong momentum of our business and the litany of uncertainties within the global economy:
Q3 FY26 outlook | ||
Sales | $1,375 - $1,415 million | |
Sales growth (in US dollars, year over year) | 3% - 6% | |
Sales growth (in constant currency, year over year) | 1% - 4% | |
Non-GAAP operating income | $270 - $290 million |
Financial Results Videoconference and Webcast
Logitech will hold a financial results videoconference to discuss the results for Q2 Fiscal Year 2026 on Tuesday, October 28, 2025 at 1:30 p.m. Pacific Daylight Time (PDT) and 09:30 p.m. Central European Time (CET).
A livestream of the event will be available on the Logitech corporate website at https://ir.logitech.com. This press release and the Q2 Fiscal Year 2026 Shareholder Letter are also available there.
Use of Non-GAAP Financial Information and Constant Currency
To facilitate comparisons to Logitech’s historical results, Logitech has included non-GAAP adjusted measures in this press release, which exclude share-based compensation expense, amortization of intangible assets, acquisition-related costs, restructuring charges (credits), net, loss (gain) on investments, non-GAAP income tax adjustment, and other items detailed under “Supplemental Financial Information” after the tables below and posted to our website at https://ir.logitech.com. Logitech also presents percentage sales growth in constant currency (“cc”), a non-GAAP measure, to show performance unaffected by fluctuations in currency exchange rates. Percentage sales growth in constant currency is calculated by translating prior period sales in each local currency at the current period’s average exchange rate for that currency and comparing that to current period sales. Logitech believes this information, used together with the GAAP financial information, will help investors to evaluate its current period performance, outlook and trends in its business. With respect to the Company’s outlook for non-GAAP operating income, most of the excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy. Therefore, no reconciliation to the GAAP amounts has been provided for the third quarter of Fiscal Year 2026 non-GAAP outlook.
Public Dissemination of Certain Information
Recordings of Logitech’s earnings videoconferences and certain events Logitech participates in or hosts, with members of the investment community are posted on the company’s investor relations website at https://ir.logitech.com. Additionally, Logitech provides notifications of news or announcements regarding its operations and financial performance, including its filings with the Securities and Exchange Commission (SEC), investor events, and press and earnings releases as part of its investor relations website. Logitech intends to use its investor relations website as means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Logitech’s corporate governance information also is available on its investor relations website.
About Logitech
Logitech designs software-enabled hardware solutions that help businesses thrive and bring people together when working, creating and gaming. As the point of connection between people and the digital world, our mission is to extend human potential in work and play, in a way that is good for people and the planet. Founded in 1981, Logitech International is a Swiss public company listed on the SIX Swiss Exchange (LOGN) and on the Nasdaq Global Select Market (LOGI). Find Logitech and its other brands, including Logitech G, at www.logitech.com or company blog.
This press release contains forward-looking statements within the meaning of the U.S. federal securities laws, including, without limitation, statements regarding: our preliminary financial results for the three and six months ended September 30, 2025; Q3 FY26 outlook, including for net sales and non-GAAP operating income, growth expectations, and related assumptions. The forward-looking statements in this press release are subject to risks and uncertainties that could cause Logitech’s actual results and events to differ materially from those anticipated in these forward-looking statements, including, without limitation: macroeconomic and geopolitical conditions and other factors and their impact, for example the resilience of overall consumer demand, B2B and IT spending levels, changes in inflation levels and monetary policies, governments’ fiscal policies, and geopolitical conflicts; our expectations regarding our expense discipline efforts, including the timing thereof; changes in secular trends that impact our business; if our product offerings, marketing activities and investment prioritization decisions do not result in the sales, profitability or profitability growth we expect, or when we expect it; if we fail to innovate and develop new products in a timely and cost-effective manner for our new and existing product categories; issues relating to development and use of artificial intelligence; if we do not successfully execute on our growth opportunities or our growth opportunities are more limited than we expect; the effect of demand variability, supply shortages and other supply chain challenges; the effect of logistics challenges, including disruptions in logistics; the effect of pricing, product, marketing and other initiatives by our competitors, and our reaction to them, on our sales, gross margins and profitability; if we are not able to maintain and enhance our brands; if our products and marketing strategies fail to separate our products from competitors’ products; if we do not efficiently manage our spending; our expectations regarding our restructuring efforts, including the timing thereof; if there is a deterioration of business and economic conditions in one or more of our sales regions or product categories, or significant fluctuations in exchange rates; changes in trade regulations, policies and agreements and the imposition of tariffs or other trade restrictions that affect our products or operations and our ability to mitigate; if we do not successfully execute on strategic acquisitions and investments; risks associated with acquisitions; and the effect of changes to our effective income tax rates. A detailed discussion of these and other risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in Logitech’s periodic filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 and other reports filed with the SEC, available at www.sec.gov, under the caption Risk Factors and elsewhere. Logitech does not undertake any obligation to update any forward-looking statements to reflect new information or events or circumstances occurring after the date of this press release.
Note that unless noted otherwise, comparisons are year over year.
Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A. and/or its affiliates in the U.S. and other countries. All other trademarks are the property of their respective owners. For more information about Logitech and its products, visit the company’s website at www.logitech.com.
LOGITECH INTERNATIONAL S.A. | ||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||
(In thousands, except per share amounts) - unaudited | ||||||||||||||
Three Months Ended
| Six Months Ended
| |||||||||||||
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | 2025 | 2024 | 2025 | 2024 | ||||||||||
Net sales | $ | 1,186,056 | $ | 1,116,034 | $ | 2,333,759 | $ | 2,204,251 | ||||||
Cost of goods sold | 669,418 | 627,491 | 1,336,010 | 1,247,008 | ||||||||||
Amortization of intangible assets | 2,182 | 2,452 | 4,331 | 4,894 | ||||||||||
Gross profit | 514,456 | 486,091 | 993,418 | 952,349 | ||||||||||
Operating expenses: | ||||||||||||||
Marketing and selling | 198,993 | 201,863 | 394,789 | 398,768 | ||||||||||
Research and development | 76,110 | 76,205 | 150,697 | 151,512 | ||||||||||
General and administrative | 41,802 | 44,173 | 83,599 | 81,631 | ||||||||||
Amortization of intangible assets and acquisition-related costs | 1,818 | 2,725 | 4,464 | 5,428 | ||||||||||
Restructuring charges, net | 4,442 | 229 | 6,484 | 615 | ||||||||||
Total operating expenses | 323,165 | 325,195 | 640,033 | 637,954 | ||||||||||
Operating income | 191,291 | 160,896 | 353,385 | 314,395 | ||||||||||
Interest income | 11,828 | 14,637 | 23,057 | 30,427 | ||||||||||
Other income (expense), net | (64 | ) | 533 | 1,098 | (1,365 | ) | ||||||||
Income before income taxes | 203,055 | 176,066 | 377,540 | 343,457 | ||||||||||
Provision for income taxes | 32,385 | 30,583 | 60,855 | 56,141 | ||||||||||
Net income | $ | 170,670 | $ | 145,483 | $ | 316,685 | $ | 287,316 | ||||||
Net income per share: | ||||||||||||||
Basic | $ | 1.16 | $ | 0.95 | $ | 2.15 | $ | 1.88 | ||||||
Diluted | $ | 1.15 | $ | 0.95 | $ | 2.13 | $ | 1.86 | ||||||
Weighted average shares used to compute net income per share: | ||||||||||||||
Basic | 147,123 | 152,460 | 147,487 | 152,875 | ||||||||||
Diluted | 148,422 | 153,672 | 148,731 | 154,320 | ||||||||||
LOGITECH INTERNATIONAL S.A. | ||||||||
PRELIMINARY RESULTS* | ||||||||
(In thousands, except per share amounts) - unaudited | ||||||||
September 30, | March 31, | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | 2025 | 2025 | ||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,375,807 | $ | 1,503,205 | ||||
Accounts receivable, net | 703,895 | 454,546 | ||||||
Inventories | 517,673 | 503,747 | ||||||
Other current assets | 152,376 | 131,211 | ||||||
Total current assets | 2,749,751 | 2,592,709 | ||||||
Non-current assets: | ||||||||
Property, plant and equipment, net | 118,218 | 113,858 | ||||||
Goodwill | 465,752 | 463,230 | ||||||
Other intangible assets, net | 16,306 | 24,630 | ||||||
Other assets | 357,198 | 344,077 | ||||||
Total assets | $ | 3,707,225 | $ | 3,538,504 | ||||
Current liabilities: | ||||||||
Accounts payable | $ | 583,308 | $ | 414,586 | ||||
Accrued and other current liabilities | 698,055 | 686,503 | ||||||
Total current liabilities | 1,281,363 | 1,101,089 | ||||||
Non-current liabilities: | ||||||||
Income taxes payable | 103,206 | 88,483 | ||||||
Other non-current liabilities | 239,643 | 221,512 | ||||||
Total liabilities | 1,624,212 | 1,411,084 | ||||||
Shareholders’ equity: | ||||||||
Registered shares, CHF 0.25 par value
| 28,001 | 29,432 | ||||||
Additional paid-in capital | 85,347 | 82,591 | ||||||
Shares in treasury, at cost
| (890,617 | ) | (1,464,912 | ) | ||||
Retained earnings | 2,986,776 | 3,627,261 | ||||||
Accumulated other comprehensive loss | (126,494 | ) | (146,952 | ) | ||||
Total shareholders’ equity | 2,083,013 | 2,127,420 | ||||||
Total liabilities and shareholders’ equity | $ | 3,707,225 | $ | 3,538,504 | ||||
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||
(In thousands) - unaudited | ||||||||||||||||
Three Months Ended
| Six Months Ended
| |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | 2025 | 2024 | 2025 | 2024 | ||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income | $ | 170,670 | $ | 145,483 | $ | 316,685 | $ | 287,316 | ||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
Depreciation | 15,871 | 14,597 | 30,935 | 29,103 | ||||||||||||
Amortization of intangible assets | 4,000 | 5,092 | 8,795 | 10,171 | ||||||||||||
Loss on investments | 104 | 413 | 497 | 1,599 | ||||||||||||
Share-based compensation expense | 30,312 | 26,469 | 63,140 | 49,874 | ||||||||||||
Deferred income taxes | 10,083 | 4,827 | 22,196 | 16,489 | ||||||||||||
Other | 13 | 81 | (12 | ) | 57 | |||||||||||
Changes in assets and liabilities: | ||||||||||||||||
Accounts receivable, net | (69,092 | ) | (27,616 | ) | (235,859 | ) | (81,568 | ) | ||||||||
Inventories | (19,084 | ) | (54,812 | ) | (1,780 | ) | (93,907 | ) | ||||||||
Other assets | 2,333 | (2,666 | ) | (17,484 | ) | 2,241 | ||||||||||
Accounts payable | 30,416 | (652 | ) | 165,419 | 108,376 | |||||||||||
Accrued and other liabilities | 53,211 | 54,786 | 1,350 | 12,280 | ||||||||||||
Net cash provided by operating activities | 228,837 | 166,002 | 353,882 | 342,031 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Purchases of property, plant and equipment | (16,557 | ) | (14,527 | ) | (32,833 | ) | (29,113 | ) | ||||||||
Purchases of deferred compensation investments | (776 | ) | (2,905 | ) | (4,037 | ) | (3,600 | ) | ||||||||
Proceeds from sales of deferred compensation investments | 1,821 | 1,561 | 3,559 | 2,299 | ||||||||||||
Other investing activities | (682 | ) | (96 | ) | (983 | ) | (912 | ) | ||||||||
Net cash used in investing activities | (16,194 | ) | (15,967 | ) | (34,294 | ) | (31,326 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||||||
Payment of cash dividends | (233,059 | ) | (207,853 | ) | (233,059 | ) | (207,853 | ) | ||||||||
Purchases of registered shares | (106,606 | ) | (132,286 | ) | (228,263 | ) | (263,185 | ) | ||||||||
Proceeds from exercises of stock options and purchase rights | 18,451 | 15,617 | 21,713 | 20,235 | ||||||||||||
Tax withholdings related to net share settlements of restricted stock units | (2,173 | ) | (2,390 | ) | (18,211 | ) | (21,243 | ) | ||||||||
Other financing activities | — | (2,908 | ) | — | (2,908 | ) | ||||||||||
Net cash used in financing activities | (323,387 | ) | (329,820 | ) | (457,820 | ) | (474,954 | ) | ||||||||
Effect of exchange rate changes on cash and cash equivalents | (1,271 | ) | 8,681 | 10,834 | 6,683 | |||||||||||
Net decrease in cash and cash equivalents | (112,015 | ) | (171,104 | ) | (127,398 | ) | (157,566 | ) | ||||||||
Cash and cash equivalents, beginning of the period | 1,487,822 | 1,534,380 | 1,503,205 | 1,520,842 | ||||||||||||
Cash and cash equivalents, end of the period | $ | 1,375,807 | $ | 1,363,276 | $ | 1,375,807 | $ | 1,363,276 | ||||||||
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||||
(In thousands) - unaudited | ||||||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | Three Months Ended
| Six Months Ended
| ||||||||||||||||
NET SALES | 2025 | 2024 | Change | 2025 | 2024 | Change | ||||||||||||
Net sales by product category: | ||||||||||||||||||
Gaming (1) | $ | 323,305 | $ | 300,470 | 8 | % | $ | 639,180 | $ | 609,945 | 5 | % | ||||||
Keyboards & Combos | 235,870 | 209,936 | 12 | 458,362 | 425,269 | 8 | ||||||||||||
Pointing Devices | 221,094 | 195,936 | 13 | 416,874 | 385,882 | 8 | ||||||||||||
Video Collaboration | 167,677 | 159,660 | 5 | 334,393 | 306,702 | 9 | ||||||||||||
Webcams | 83,301 | 80,249 | 4 | 167,676 | 153,153 | 9 | ||||||||||||
Tablet Accessories | 85,061 | 85,614 | (1 | ) | 176,288 | 164,153 | 7 | |||||||||||
Headsets | 43,498 | 46,916 | (7 | ) | 89,020 | 91,152 | (2 | ) | ||||||||||
Other (2) | 26,250 | 37,253 | (30 | ) | 51,966 | 67,995 | (24 | ) | ||||||||||
Total Net Sales | $ | 1,186,056 | $ | 1,116,034 | 6 | % | $ | 2,333,759 | $ | 2,204,251 | 6 | % | ||||||
(1) | Gaming includes streaming services revenue generated by Streamlabs. | |
(2) | Other primarily consists of mobile speakers and PC speakers. |
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||
(In thousands, except per share amounts) - unaudited | ||||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | Three Months Ended
| Six Months Ended
| ||||||||||||||
GAAP TO NON-GAAP RECONCILIATION (A) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
Gross profit - GAAP | $ | 514,456 | $ | 486,091 | $ | 993,418 | $ | 952,349 | ||||||||
Share-based compensation expense | 3,359 | 3,902 | 5,739 | 6,500 | ||||||||||||
Amortization of intangible assets | 2,182 | 2,452 | 4,331 | 4,894 | ||||||||||||
Gross profit - Non-GAAP | $ | 519,997 | $ | 492,445 | $ | 1,003,488 | $ | 963,743 | ||||||||
Gross margin - GAAP | 43.4 | % | 43.6 | % | 42.6 | % | 43.2 | % | ||||||||
Gross margin - Non-GAAP | 43.8 | % | 44.1 | % | 43.0 | % | 43.7 | % | ||||||||
Operating expenses - GAAP | $ | 323,165 | $ | 325,195 | $ | 640,033 | $ | 637,954 | ||||||||
Less: Share-based compensation expense | 26,953 | 22,567 | 57,401 | 43,374 | ||||||||||||
Less: Amortization of intangible assets and acquisition-related costs | 1,818 | 2,725 | 4,464 | 5,428 | ||||||||||||
Less: Restructuring charges, net | 4,442 | 229 | 6,484 | 615 | ||||||||||||
Operating expenses - Non-GAAP | $ | 289,952 | $ | 299,674 | $ | 571,684 | $ | 588,537 | ||||||||
% of net sales - GAAP | 27.2 | % | 29.1 | % | 27.4 | % | 28.9 | % | ||||||||
% of net sales - Non-GAAP | 24.4 | % | 26.9 | % | 24.5 | % | 26.7 | % | ||||||||
Operating income - GAAP | $ | 191,291 | $ | 160,896 | $ | 353,385 | $ | 314,395 | ||||||||
Share-based compensation expense | 30,312 | 26,469 | 63,140 | 49,874 | ||||||||||||
Amortization of intangible assets and acquisition-related costs | 4,000 | 5,177 | 8,795 | 10,322 | ||||||||||||
Restructuring charges, net | 4,442 | 229 | 6,484 | 615 | ||||||||||||
Operating income - Non-GAAP | $ | 230,045 | $ | 192,771 | $ | 431,804 | $ | 375,206 | ||||||||
% of net sales - GAAP | 16.1 | % | 14.4 | % | 15.1 | % | 14.3 | % | ||||||||
% of net sales - Non-GAAP | 19.4 | % | 17.3 | % | 18.5 | % | 17.0 | % | ||||||||
Net income - GAAP | $ | 170,670 | $ | 145,483 | $ | 316,685 | $ | 287,316 | ||||||||
Share-based compensation expense | 30,312 | 26,469 | 63,140 | 49,874 | ||||||||||||
Amortization of intangible assets and acquisition-related costs | 4,000 | 5,177 | 8,795 | 10,322 | ||||||||||||
Restructuring charges, net | 4,442 | 229 | 6,484 | 615 | ||||||||||||
Loss on investments | 104 | 413 | 497 | 1,599 | ||||||||||||
Non-GAAP income tax adjustment | 6,047 | 6,315 | 8,142 | 8,985 | ||||||||||||
Net income - Non-GAAP | $ | 215,575 | $ | 184,086 | $ | 403,743 | $ | 358,711 | ||||||||
Net income per share: | ||||||||||||||||
Diluted - GAAP | $ | 1.15 | $ | 0.95 | $ | 2.13 | $ | 1.86 | ||||||||
Diluted - Non-GAAP | $ | 1.45 | $ | 1.20 | $ | 2.71 | $ | 2.32 | ||||||||
Shares used to compute net income per share: | ||||||||||||||||
Diluted - GAAP and Non-GAAP | 148,422 | 153,672 | 148,731 | 154,320 | ||||||||||||
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||
(In thousands) - unaudited | ||||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | Three Months Ended
| Six Months Ended
| ||||||||||||||
SHARE-BASED COMPENSATION EXPENSE | 2025 | 2024 | 2025 | 2024 | ||||||||||||
Share-based Compensation Expense | ||||||||||||||||
Cost of goods sold | $ | 3,359 | $ | 3,902 | $ | 5,739 | $ | 6,500 | ||||||||
Marketing and selling | 12,141 | 10,469 | 26,071 | 22,320 | ||||||||||||
Research and development | 5,666 | 5,067 | 12,017 | 10,806 | ||||||||||||
General and administrative | 9,146 | 7,031 | 19,313 | 10,248 | ||||||||||||
Total share-based compensation expense | 30,312 | 26,469 | 63,140 | 49,874 | ||||||||||||
Income tax benefit | (6,015 | ) | (4,776 | ) | (10,921 | ) | (12,378 | ) | ||||||||
Total share-based compensation expense, net of income tax benefit | $ | 24,297 | $ | 21,693 | $ | 52,219 | $ | 37,496 | ||||||||
*Note: These preliminary results for the three and six months ended September 30, 2025 are subject to adjustments, including subsequent events that may occur through the date of filing our Quarterly Report on Form 10-Q. |
(A) Non-GAAP Financial Measures
To supplement our condensed consolidated financial results prepared in accordance with GAAP, we use a number of financial measures, both GAAP and non-GAAP, in analyzing and assessing our overall business performance, for making operating decisions and for forecasting and planning future periods. We consider the use of non-GAAP financial measures helpful in assessing our current financial performance, ongoing operations and prospects for the future as well as understanding financial and business trends relating to our financial condition and results of operations.
While we use non-GAAP financial measures as a tool to enhance our understanding of certain aspects of our financial performance and to provide incremental insight into the underlying factors and trends affecting both our performance and our cash-generating potential, we do not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial measures. Consistent with this approach, we believe that disclosing non-GAAP financial measures to the readers of our financial statements provides useful supplemental data that, while not a substitute for GAAP financial measures, can offer insight in the review of our financial and operational performance and enable investors to more fully understand trends in our current and future performance. In assessing our business during the quarter ended September 30, 2025 and prior periods presented, we excluded items in the following general categories, each of which are described below:
Share-based compensation expense. We believe that providing non-GAAP measures excluding share-based compensation expense, in addition to the GAAP measures, allows for a more transparent comparison of our financial results from period to period. We prepare and maintain our budgets and forecasts for future periods on a basis consistent with this non-GAAP financial measure. Further, companies use a variety of types of equity awards as well as a variety of methodologies, assumptions and estimates to determine share-based compensation expense. We believe that excluding share-based compensation expense enhances our ability and the ability of investors to understand the impact of non-cash share-based compensation on our operating results and to compare our results against the results of other companies.
Amortization of intangible assets. We incur intangible asset amortization expense, primarily in connection with our acquisitions of various businesses and technologies. The amortization of purchased intangibles varies depending on the level of acquisition activity. We exclude these various charges in budgeting, planning and forecasting future periods and we believe that providing the non-GAAP measures excluding these various non-cash charges, as well as the GAAP measures, provides additional insight when comparing our gross profit, operating expenses, and financial results from period to period.
Acquisition-related costs. We incurred expenses in connection with our acquisitions which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. Acquisition-related costs include certain incremental expenses incurred to effect a business combination. We believe that providing the non-GAAP measures excluding these costs, as well as the GAAP measures, assists our investors because such costs are not reflective of our ongoing operating results.
Restructuring charges (credits), net. These charges (credits) are associated with restructuring plans and will vary based on the initiatives in place during any given period. Restructuring charges may include costs related to employee terminations, facility closures and early cancellation of certain contracts as well as other costs resulting from our restructuring initiatives. We believe that providing the non-GAAP measures excluding these items, as well as the GAAP measures, assists our investors because such charges (credits) are not reflective of our ongoing operating results.
Loss (gain) on investments. We recognize losses (gains) related to our investments in various companies, which vary depending on the operational and financial performance of the companies in which we invest. These amounts include our losses (earnings) on equity method investments as well as investment impairments and losses (gains) resulting from sales or other events related to our investments. We believe that providing the non-GAAP measures excluding these items, as well as the GAAP measures, assists our investors because such losses (gains) are not reflective of our ongoing operations.
Non-GAAP income tax adjustment. Non-GAAP income tax adjustment primarily measures the income tax effect of non-GAAP adjustments excluded above as well as the income tax impact of non-recurring deferred taxes, tax settlements, and other non-routine tax events, the determination of which is based upon the nature of the underlying items.
Each of the non-GAAP financial measures described above, and used in this press release, should not be considered in isolation from, or as a substitute for, a measure of financial performance prepared in accordance with GAAP. Further, investors are cautioned that there are inherent limitations associated with the use of each of these non-GAAP financial measures as an analytical tool. In particular, these non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles and many of the adjustments to the GAAP financial measures reflect the exclusion of items that are recurring and may be reflected in the Company’s financial results for the foreseeable future. We compensate for these limitations by providing specific information in the reconciliation included in this press release regarding the GAAP amounts excluded from the non-GAAP financial measures. In addition, as noted above, we evaluate the non-GAAP financial measures together with the most directly comparable GAAP financial information.
Additional Supplemental Financial Information - Constant Currency
In addition, Logitech presents percentage sales growth in constant currency to show performance unaffected by fluctuations in currency exchange rates. Percentage sales growth in constant currency is calculated by translating prior period sales in each local currency at the current period’s average exchange rate for that currency and comparing that to current period sales.
(LOGIIR)
View source version on businesswire.com: https://www.businesswire.com/news/home/20251028011553/en/
Contacts
Editorial Contacts:
Nate Melihercik, Head of Investor Relations - ir@logitech.com
Bruno Rodriguez, Head of Corporate Communications - mediarelations@logitech.com
Ben Starkie, Corporate Communications - +41 (0)79-292-3499,
bstarkie1@logitech.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom